Immune microenvironment in osteosarcoma: components, therapeutic strategies and clinical applications
T Zhu, J Han, L Yang, Z Cai, W Sun, Y Hua… - Frontiers in …, 2022 - frontiersin.org
Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents,
and the 5-year event-free survival rate has not improved significantly in the past three …
and the 5-year event-free survival rate has not improved significantly in the past three …
Impact of cancer metabolism on therapy resistance–clinical implications
AC Gonçalves, E Richiardone, J Jorge, B Polónia… - Drug Resistance …, 2021 - Elsevier
Despite an increasing arsenal of anticancer therapies, many patients continue to have poor
outcomes due to the therapeutic failures and tumor relapses. Indeed, the clinical efficacy of …
outcomes due to the therapeutic failures and tumor relapses. Indeed, the clinical efficacy of …
Recent insights into therapy resistance in osteosarcoma
ZD Prudowsky, JT Yustein - Cancers, 2020 - mdpi.com
Simple Summary Osteosarcoma is the most common cancer of the bone for children and
adolescents. Although chemotherapy regimens have been widely available and effective for …
adolescents. Although chemotherapy regimens have been widely available and effective for …
Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and RCC models
A Filipiak-Duliban, K Brodaczewska, A Kajdasz… - International journal of …, 2022 - mdpi.com
2D culture as a model for drug testing often turns to be clinically futile. Therefore, 3D cultures
(3Ds) show potential to better model responses to drugs observed in vivo. In preliminary …
(3Ds) show potential to better model responses to drugs observed in vivo. In preliminary …
[HTML][HTML] The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
B Polónia, CPR Xavier, J Kopecka, C Riganti… - Cytokine & Growth …, 2023 - Elsevier
In order to adapt to a higher proliferative rate and an increased demand for energy sources,
cancer cells rewire their metabolic pathways, a process currently recognized as a hallmark …
cancer cells rewire their metabolic pathways, a process currently recognized as a hallmark …
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
IC Salaroglio, DC Belisario, M Akman… - Journal of experimental …, 2022 - Springer
Background Solid tumors subjected to intermittent hypoxia are characterized by resistance
to chemotherapy and immune-killing by effector T-lymphocytes, particularly tumor-infiltrating …
to chemotherapy and immune-killing by effector T-lymphocytes, particularly tumor-infiltrating …
Cholesterol metabolism: At the cross road between cancer cells and immune environment
J Kopecka, M Godel, C Riganti - The International Journal of Biochemistry & …, 2020 - Elsevier
Mevalonate pathway is a highly conserved pathway that produces isoprenoids and
cholesterol, and it is often increased in cancer cells. Cholesterol, upstream metabolites …
cholesterol, and it is often increased in cancer cells. Cholesterol, upstream metabolites …
Dual function of protein phosphatase 5 (PPP5C): An emerging therapeutic target for drug discovery
H Zhang, Q Zhang, J Tu, Q You, L Wang - European Journal of Medicinal …, 2023 - Elsevier
Phosphorylation of proteins is reversibly controlled by the kinases and phosphatases in
many posttranslational regulation patterns. Protein phosphatase 5 (PPP5C) is a …
many posttranslational regulation patterns. Protein phosphatase 5 (PPP5C) is a …
Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin
M Cortini, F Macchi, F Reggiani, E Vitale, MV Lipreri… - Cancers, 2023 - mdpi.com
Simple Summary The pathogenesis of osteosarcoma relies on complex interactions
between developing cancer and surrounding tissue, which includes proteins of the …
between developing cancer and surrounding tissue, which includes proteins of the …
Strategies to overcome resistance to immune-based therapies in osteosarcoma
CM Hattinger, IC Salaroglio, L Fantoni, M Godel… - International Journal of …, 2023 - mdpi.com
Improving the prognosis and cure rate of HGOSs (high-grade osteosarcomas) is an absolute
need. Immune-based treatment approaches have been increasingly taken into …
need. Immune-based treatment approaches have been increasingly taken into …